Intelligent Bio Solutions (NASDAQ: $INBS ): AI Bio
Post# of 122
(Total Views: 183)
Posted On: 05/30/2023 2:59:27 PM
Intelligent Bio Solutions (NASDAQ: $INBS ): AI Biomedical Stock On Radar For June
https://thestreetreports.com/intelligent-bio-...-for-june/
If you are currently looking into medical device companies then you could consider taking a look into Intelligent Bio Solutions Inc (NASDAQ:INBS). This past Friday the company’s stock had come into prime focus and ended up with gains of 4.90%. It is perhaps also interesting to note that the company has low outstanding shares and a fairly low market capitalization of only $2.5 million.
Hence, investors who are interested in long-term investment may find it fairly appealing. The company, which is listed on NASDAQ, is best known for offering fast, cost-effective non-invasive testing solutions. Its flagship product is the Intelligent Fingerprinting Drug Screening System, which is bringing about a paradigm shift in portable testing through fingerprinting sweat analysis space. Additionally, the technology could also have significant applications in other industries.
The company announced on May 16 that it was going to add the opioid substance fentanyl and fentanyl-laced street drugs to the list of substances that could be detected by sweat testing by its Intelligent Fingerprinting Drug Screening System. It was a significant addition considering the fact the data from CDC for the 12 months ending November 2022 revealed overdose deaths had touched more than 100,000.
Out of those, as much as 81.9% involved an opioid. Fentanyl is currently the most popular opioid that is involved in such overdose deaths. This is one way in which Intelligent Bio Solutions is going to work on tackling the opioid crisis that has wreaked havoc all over the United States.
https://thestreetreports.com/intelligent-bio-...-for-june/
If you are currently looking into medical device companies then you could consider taking a look into Intelligent Bio Solutions Inc (NASDAQ:INBS). This past Friday the company’s stock had come into prime focus and ended up with gains of 4.90%. It is perhaps also interesting to note that the company has low outstanding shares and a fairly low market capitalization of only $2.5 million.
Hence, investors who are interested in long-term investment may find it fairly appealing. The company, which is listed on NASDAQ, is best known for offering fast, cost-effective non-invasive testing solutions. Its flagship product is the Intelligent Fingerprinting Drug Screening System, which is bringing about a paradigm shift in portable testing through fingerprinting sweat analysis space. Additionally, the technology could also have significant applications in other industries.
The company announced on May 16 that it was going to add the opioid substance fentanyl and fentanyl-laced street drugs to the list of substances that could be detected by sweat testing by its Intelligent Fingerprinting Drug Screening System. It was a significant addition considering the fact the data from CDC for the 12 months ending November 2022 revealed overdose deaths had touched more than 100,000.
Out of those, as much as 81.9% involved an opioid. Fentanyl is currently the most popular opioid that is involved in such overdose deaths. This is one way in which Intelligent Bio Solutions is going to work on tackling the opioid crisis that has wreaked havoc all over the United States.
(0)
(0)